Study of the Safety & Efficacy of Leukine® in the Treatment of Alzheimer's Disease

NCT01409915 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: Sagramostim
DRUG: Saline -- placebo comparator

Sponsor

University of Colorado, Denver

Collaborators

[object Object]